Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 9, 2021.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
The chief medical officer of Scholar Rock provided background on the company’s investigational spinal muscular atrophy therapy apitegromab and its clinical benefit when applied with an existing nusinersen (Spinraza; Biogen) treatment regimen.
The newly updated FDA label language emphasizes the Alzheimer disease stages in which aducanumab was studied, with no additional changes made to its approval pathway, with adjustments focused mainly on the Indications and Usage section of the label.
In episode 5 of the "Recognizing and Managing Advanced Parkinson Disease" NeurologyLive Peer Exchange series, experts in the care of patients with Parkinson disease Adolfo Ramirez-Zamora, MD; Joohi Jimenez-Shahed, MD; Aristide Merola, MD, PhD; Michael J. Soileau, MD, hold a discussion about how to educate and speak with patients with advanced disease.
Since 2016, there has been consistent growth in the number of Alzheimer disease trials sponsored both in part and fully by academic medical centers and/or the National Institutes of Health, as well as by public-private partnerships.
Experts in multiple sclerosis, including Fred D. Lublin, MD; Ravi Dukkipati, MD; Gavin Giovannoni, MD; and Lauren Gluck, MD, provide an overview of treatment strategies and selection in relapsing MS in episode 2 of the NeurologyLive Peer Exchange series, "Optimal Management of Relapsing Multiple Sclerosis."
In case you missed it: NeurologyLive is once again running our quarterly audience survey! We kindly ask you to share 5 minutes of your time with us in order to help us better understand how you use social media and how we can better serve you across different platforms.
The fourth installment of our webinar series, "The Ever-Changing Face of Multiple Sclerosis," put on in partnership with the Consortium of Multiple Sclerosis Centers, is set for Wednesday, July 21, at 7:00 PM ET. This time, the conversation will focus on the evolving rehabilitation strategies for patients with MS, and will feature Ahmed Obeidat, MD, PhD; Nicholas C. Ketchum, MD; Francois Bethoux, MD, who aim to share their insight into gait and ambulation issues, spasticity and its management, the incorporation of technology into rehabilitation, and the traditional versus nontraditional approaches,